Mumbai: Leading hepatology experts gathered to discuss advancements in managing advanced liver disease without transplants. Discussions covered topics such as liver regeneration in decompensated cirrhosis, the liver-heart connection in MASH cirrhosis, and potential new treatments. A significant focus was on understanding cell death mechanisms like apoptosis, necroptosis, pyroptosis, and ferroptosis in liver diseases. The impact of liver disease on neurocognitive decline was also highlighted.
The APASL BUILD 3.0 (Brainstorming, Update, and Innovations in Liver Diseases) Conference was led by Dr Akash Shukla, Director & Consultant, Department of Hepatology at Sir H.N. Reliance Foundation Hospital (HN RFH).
Key discussions centered on enhancing patient outcomes, particularly in ICU care, and exploring complex aspects of liver disease. Experts examined topics such as liver regeneration in decompensated cirrhosis, the liver-heart connection in MASH cirrhosis, and potential new treatments.
Dr Tarang Gianchandani, CEO, Sir H.N. Reliance Foundation Hospital, emphasized the urgency of early detection, said,“Liver disease is a growing global crisis, often diagnosed too late, leading to dire outcomes. It is the 10th leading cause of mortality in India. Greater awareness is needed, similar to that for cancer and heart diseases. At HN RFH, our expertise in AI-driven predictive analytics will soon help identify liver disease at an early stage, giving patients a real chance at recovery.”
